Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-09-04 Sale | 2024-09-05 4:13 pm | Karyopharm Therapeutics Inc. | KPTI | Cheng Sohanya Roshan EVP & Chief Commercial Officer | 5,356 | $0.7218 | $3,866 | 404,051 (Direct) | View |
| 2024-02-29 Sale | 2024-03-04 7:37 pm | Karyopharm Therapeutics Inc. | KPTI | Cheng Sohanya Roshan EVP & Chief Commercial Officer | 26,949 | $1.1757 | $31,684 | 393,509 (Direct) | View |
| 2023-09-01 Sale | 2023-09-05 4:27 pm | Karyopharm Therapeutics Inc. | KPTI | Cheng Sohanya Roshan EVP & Chief Commercial Officer | 7,415 | $1.3313 | $9,872 | 204,086 (Direct) | View |
| 2023-06-08 Sale | 2023-06-12 4:07 pm | Karyopharm Therapeutics Inc. | KPTI | Cheng Sohanya Roshan EVP & Chief Commercial Officer | 1,839 | $2.35 | $4,322 | 211,501 (Direct) | View |
| 2023-03-01 Sale | 2023-03-02 5:33 pm | Karyopharm Therapeutics Inc. | KPTI | Cheng Sohanya Roshan EVP & Chief Commercial Officer | 11,239 | $3.0292 | $34,045 | 210,687 (Direct) | View |
| 2022-06-13 Sale | 2022-06-14 7:25 pm | Karyopharm Therapeutics Inc. | KPTI | Cheng Sohanya Roshan Chief Commercial Officer | 1,551 | $5.2062 | $8,075 | 89,949 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-10-31 Option Award | 2024-11-01 4:31 pm | N/A 2034-10-31 | Carisma Therapeutics Inc. | CARM | Cheng Sohanya Roshan Director | 38,700 | $0 | 38,700 (Direct) | View |
| 2024-02-28 Option Award | 2024-02-29 5:35 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Cheng Sohanya Roshan EVP & Chief Commercial Officer | 198,959 | $0 | 420,458 (Direct) | View |
| 2024-01-24 Option Award | 2024-01-25 7:40 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Cheng Sohanya Roshan EVP & Chief Commercial Officer | 14,167 | $0 | 221,499 (Direct) | View |
| 2023-02-28 Option Award | 2023-03-02 5:33 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Cheng Sohanya Roshan EVP & Chief Commercial Officer | 100,000 | $0 | 210,687 (Direct) | View |
| 2022-08-31 Option Award | 2022-09-01 9:00 pm | N/A 2032-08-30 | Karyopharm Therapeutics Inc. | KPTI | Cheng Sohanya Roshan EVP & Chief Commercial Officer | 75,000 | $0 | 164,949 (Direct) | View |
| 2022-02-28 Option Award | 2022-03-02 3:15 pm | N/A 2032-02-27 | Karyopharm Therapeutics Inc. | KPTI | Cheng Sohanya Roshan Chief Commercial Officer | 192,000 | $0 | 199,500 (Direct) | View |
| 2021-06-30 Option Award | 2021-07-01 4:33 pm | N/A 2031-06-29 | Karyopharm Therapeutics Inc. | KPTI | Cheng Sohanya Roshan SVP Sales & Commercial Ops | 132,500 | $0 | 132,500 (Direct) | View |